Targeted in situ gene correction of dysfunctional APOE alleles to produce atheroprotective plasma ApoE3 protein

Cardiology Research and Practice

Volumn 1, Issue 1, 2012, Pages

  Papaioannou, Ioannis ^a   Simons, J Paul ^a   Owen, James S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; ENDONUCLEASE; OLIGONUCLEOTIDE; PLASMID DNA; SINGLE STRANDED DNA;

ADENOVIRUS; ANTIINFLAMMATORY ACTIVITY; AORTA ATHEROSCLEROSIS; APOLIPOPROTEIN E GENE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BINDING SITE; DNA BINDING MOTIF; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; EX VIVO STUDY; EXON; GENE; GENE FREQUENCY; GENE FUNCTION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECOMBINATION REPAIR; REVIEW; RNA EDITING; SEQUENCE ANALYSIS; TARGETED GENE REPAIR; VIRAL GENE THERAPY; WILD TYPE; XANTHOMA;

EID: 84862272272     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2012/148796     Document Type: Review

References (153)

1. Poole-Wilson P., The prevention of cardiovascular disease worldwide: whose task and WHO's task? Clinical Medicine 2005 5 4 379 384 (Pubitemid 41176220)
2. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease The New England Journal of Medicine 2005 352 16 1685 1626
3. Hausenloy D. J., Yellon D. M., Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels Current Opinion in Cardiology 2009 24 5 473 482
4. Linsel-Nitschke P., Tall A. R., HDL as a target in the treatment of atherosclerotic cardiovascular disease Nature Reviews Drug Discovery 2005 4 3 193 205 (Pubitemid 40372554)
5. Rizzo M., Rini G. B., Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia Archives of Medical Science 2011 7 1 5 7
6. Charlton-Menys V., Durrington P. N., Human cholesterol metabolism and therapeutic molecules Experimental Physiology 2008 93 1 27 42 (Pubitemid 350293976)
7. Duffy D., Rader D. J., Update on strategies to increase HDL quantity and function Nature Reviews 2009 6 7 455 463
8. Davidson M. H., Apolipoprotein A-I therapy: promise, challenges, and disappointment Journal of the American College of Cardiology 2011 57 9 1120 1121
9. deGoma E. M., Rader D. J., Novel HDL-directed pharmacotherapeutic strategies Nature Reviews Cardiology 2011 8 5 266 277
10. Bell D. A., Hooper A. J., Burnett J. R., Mipomersen, an antisense apolipoprotein B synthesis inhibitor Expert Opinion on Investigational Drugs 2011 20 2 265 272
11. Duff C. J., Hooper N. M., PCSK9: an emerging target for treatment of hypercholesterolemia Expert Opinion on Therapeutic Targets 2011 15 2 157 168
12. Soutar A. K., Unexpected roles for PCSK9 in lipid metabolism Current Opinion in Lipidology 2011 22 3 192 196
13. Smith J. D., Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis Current Opinion in Investigational Drugs 2010 11 9 989 996
14. Oka K., Belalcazar L. M., Dieker C., Nour E. A., Nuno-Gonzalez P., Paul A., Cormier S., Shin J. K., Finegold M., Chan L., Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector Gene Therapy 2007 14 3 191 202 (Pubitemid 46152622)
15. Vaessen S. F. C., Veldman R. J., Cornijn E. M., Snapper J., Sierts J. A., van den Oever K., Beattie S. G., Twisk J., Kuivenhoven J. A., AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency Journal of Gene Medicine 2009 11 8 697 707
16. Greenow K., Pearce N. J., Ramji D. P., The key role of apolipoprotein E in atherosclerosis Journal of Molecular Medicine 2005 83 5 329 342 (Pubitemid 41201798)
17. Hatters D. M., Peters-Libeu C. A., Weisgraber K. H., Apolipoprotein E structure: insights into function Trends in Biochemical Sciences 2006 31 8 445 454 (Pubitemid 44108662)
18. Eichner J. E., Dunn S. T., Perveen G., Thompson D. M., Stewart K. E., Stroehla B. C., Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review American Journal of Epidemiology 2002 155 6 487 495 (Pubitemid 34208040)
19. Mahley R. W., Huang Y., Rall S. C., Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes Journal of Lipid Research 1999 40 11 1933 1949 (Pubitemid 29523420)
20. Hopkins P. N., Wu L. L., Hunt S. C., Brinton E. A., Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease Journal of the American College of Cardiology 2005 45 7 1003 1012 (Pubitemid 40432430)
21. Sudlow C., Martnez Gonzlez N. A., Kim J., Clark C., Does Apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls Stroke 2006 37 2 364 370 (Pubitemid 43731988)
22. Bennet A. M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., De Faire U., Danesh J., Association of apolipoprotein E genotypes with lipid levels and coronary risk Journal of the American Medical Association 2007 298 11 1300 1311 (Pubitemid 47443344)
23. Song Y., Stampfer M. J., Liu S., Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease Annals of Internal Medicine 2004 141 2 137 147 (Pubitemid 38937836)
24. Wilson P. W. F., Schaefer E. J., Larson M. G., Ordovas J. M., Apolipoprotein E alleles and risk of coronary disease: a meta-analysis Arteriosclerosis, Thrombosis, and Vascular Biology 1996 16 10 1250 1255 (Pubitemid 26339712)
25. Talmud P. J., Commentary on the paper by Gustavsson et al. entitled Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women Atherosclerosis 2012 220 2 323 324
26. Gustavsson J., Mehlig K., Leander K., Strandhagen E., Bjrck L., Thelle D. S., Lissner L., Blennow K., Zetterberg H., Nyberg F., Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women Atherosclerosis 2012 220 2 486 492
27. McKay G. J., Silvestri G., Chakravarthy U., Dasari S., Fritsche L. G., Weber B. H., Keilhauer C. N., Klein M. L., Francis P. J., Klaver C. C., Vingerling J. R., Ho L., De Jong P. T.D.V., Dean M., Sawitzke J., Baird P. N., Guymer R. H., Stambolian D., Orlin A., Seddon J. M., Peter I., Wright A. F., Hayward C., Lotery A. J., Ennis S., Gorin M. B., Weeks D. E., Kuo C. L., Hingorani A. D., Sofat R., Cipriani V., Swaroop A., Othman M., Kanda A., Chen W., Abecasis G. R., Yates J. R., Webster A. R., Moore A. T., Seland J. H., Rahu M., Soubrane G., Tomazzoli L., Topouzis F., Vioque J., Young I. S., Fletcher A. E., Patterson C. C., Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people American Journal of Epidemiology 2011 173 12 1357 1364
28. Deelen J., Beekman M., Uh H. W., Helmer Q., Kuningas M., Christiansen L., Kremer D., van der Breggen R., Suchiman H. E.D., Lakenberg N., van den Akker E. B., Passtoors W. M., Tiemeier H., van Heemst D., de Craen A. J., Rivadeneira F., de Geus E. J., Perola M., van der Ouderaa F. J., Gunn D. A., Boomsma D. I., Uitterlinden A. G., Christensen K., van Duijn C. M., Heijmans B. T., Houwing-Duistermaat J. J., Westendorp R. G.J., Slagboom P. E., Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited Aging Cell 2011 10 4 686 698
29. Mooijaart S. P., Berbée J. F. P., Van Heemst D., Havekes L. M., De Craen A. J. M., Slagboom P. E., Rensen P. C. N., Westendorp R. G. J., ApoE plasma levels and risk of cardiovascular mortality in old age PLoS Medicine 2006 3 6, article 176
30. Reilly M., Rader D. J., Apolipoprotein E and coronary disease: a puzzling paradox PLoS Medicine 2006 3 6 0736 0738 (Pubitemid 43987810)
31. Mahley R. W., Huang Y., Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing Journal of Clinical Investigation 2007 117 1 94 98 (Pubitemid 46048456)
32. Mahley R. W., Weisgraber K. H., Huang Y., Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS Journal of lipid research 2009 50 S183 188
33. Murdoch S. J., Boright A. P., Paterson A. D., Zinman B., Steffes M., Cleary P., Edwards K., Marcovina S. S., Purnell J. Q., Brunzell J. D., LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes Atherosclerosis 2007 192 1 138 147 (Pubitemid 46602290)
34. Huang Y., von Eckardstein A., Wu S., Assmann G., Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma Journal of Clinical Investigation 1995 96 6 2693 2701
35. Cullen P., Cignarella A., Brennhausen B., Mohr S., Assmann G., von Eckardstein A., Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages Journal of Clinical Investigation 1998 101 8 1670 1677 (Pubitemid 28198496)
36. Fan D., Qiu S., Overton C. D., Yancey P. G., Swift L. L., Jerome W. G., Linton M. F., Fazio S., Impaired secretion of apolipoprotein E2 from macrophages The Journal of Biological Chemistry 2007 282 18 13746 13753 (Pubitemid 47100531)
37. Wouters K., Shiri-Sverdlov R., van Gorp P. J., van Bilsen M., Hofker M. H., Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice Clinical Chemistry and Laboratory Medicine 2005 43 5 470 479 (Pubitemid 41460623)
38. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell 1992 71 2 343 353
39. Sullivan P. M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R. L., Quarfordt S. H., Maeda N., Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis The Journal of Biological Chemistry 1997 272 29 17972 17980 (Pubitemid 27306374)
40. Sullivan P. M., Mezdour H., Quarfordt S. H., Maeda N., Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human APOE2 Journal of Clinical Investigation 1998 102 1 130 135 (Pubitemid 28323839)
41. Ji Z. S., Fazio S., Mahley R. W., Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia The Journal of Biological Chemistry 1994 269 18 13421 13428 (Pubitemid 24206115)
42. Curtiss L. K., ApoE in atherosclerosis: a protein with multiple hats Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 8 1852 1853 (Pubitemid 30644632)
43. Davignon J., Apolipoprotein E and atherosclerosis beyond lipid effect Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 2 267 269 (Pubitemid 40189142)
44. Zhang H., Wu L. M., Wu J., Cross-talk between apolipoprotein E and cytokines Mediators of Inflammation 2011 2011 10
45. Kelly M. E., Clay M. A., Mistry M. J., Hsieh-Li H. M., Harmony J. A. K., Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity Cellular Immunology 1994 159 2 124 139 (Pubitemid 24381044)
46. Riddell D. R., Graham A., Owen J. S., Apolipoprotein E inhibits platelet aggregation through the L- arginine:nitric oxide pathway: implications for vascular disease The Journal of Biological Chemistry 1997 272 1 89 95 (Pubitemid 27021129)
47. Stannard A. K., Riddell D. R., Sacre S. M., Tagalakis A. D., Langer C., von Eckardstein A., Cullen P., Athanasopoulos T., Dickson G., Owen J. S., Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells The Journal of Biological Chemistry 2001 276 49 46011 46016
48. Sacre S. M., Stannard A. K., Owen J. S., Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells FEBS Letters 2003 540 13 181 187 (Pubitemid 36398054)
49. Hui D. Y., Basford J. E., Distinct signaling mechanisms for apoE inhibition of cell migration and proliferation Neurobiology of Aging 2005 26 3 317 323 (Pubitemid 40082714)
50. Sklén K., Gustafsson M., Knutsen Rydberg E., Hultén L. M., Wiklund O., Innerarity T. L., Boren J., Subendothelial retention of atherogenic lipoproteins in early atherosclerosis Nature 2002 417 6890 750 754 (Pubitemid 34640629)
51. Vogel T., Guo N., Guy R., Drezlich N., Krutzsch H. C., Blake D. A., Panet A., Roberts D. D., Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation Journal of Cellular Biochemistry 1994 54 3 299 308 (Pubitemid 24097226)
52. Miyata M., Smith J. D., Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and -amyloid peptides Nature Genetics 1996 14 1 55 61 (Pubitemid 26301547)
53. Pham T., Kodvawala A., Hui D. Y., The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity Biochemistry 2005 44 20 7577 7582 (Pubitemid 40696011)
54. Mabile L., Lefebvre C., Lavigne J., Boulet L., Davignon J., Lussier-Cacan S., Bernier L., Secreted apolipoprotein E reduces macrophage-mediated LDL oxidation in an isoform-dependent way Journal of Cellular Biochemistry 2003 90 4 766 776 (Pubitemid 37392467)
55. Tsoi L. M., Wong K. Y., Liu Y. M., Ho Y. Y., Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF- and IL-6 in macrophages Archives of Biochemistry and Biophysics 2007 460 1 33 40
56. Hayek T., Oiknine J., Brook J. G., Aviram M., Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice Biochemical and Biophysical Research Communications 1994 201 3 1567 1574 (Pubitemid 24234268)
57. Grainger D. J., Reckless J., McKilligin E., Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice Journal of Immunology 2004 173 10 6366 6375 (Pubitemid 39487796)
58. Ali K., Middleton M., Puré E., Rader D. J., Apolipoprotein E suppresses the type I inflammatory response in vivo Circulation Research 2005 97 9 922 927 (Pubitemid 41552678)
59. Roselaar S. E., Daugherty A., Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo Journal of Lipid Research 1998 39 9 1740 1743 (Pubitemid 28411160)
60. De Bont, Netea, Demacker, Kullberg, Van Der Meer, Stalenhoef, Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae European Journal of Clinical Investigation 2000 30 9 818 822
61. Van Den Elzen P., Garg S., Len L., Brigl M., Leadbetter E. A., Gumperz J. E., Dascher C. C., Cheng T. Y., Sacks F. M., Illarionov P. A., Besra G. S., Kent S. C., Moody D. B., Brenner M. B., Apolipoprotein-mediated pathways of lipid antigen presentation Nature 2005 437 7060 906 910 (Pubitemid 41486768)
62. Thorngate F. E., Rudel L. L., Walzem R. L., Williams D. L., Low levels of extrahepatic nonmacrophage apoE inhibit atherosclerosis without correcting hypercholesterolemia in apoE-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 8 1939 1945 (Pubitemid 30644644)
63. Raffai R. L., Loeb S. M., Weisgraber K. H., Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 2 436 441 (Pubitemid 40189170)
64. Yamada N., Inoue I., Kawamura M., Harada K., Watanabe Y., Shimano H., Gotoda T., Shimada M., Kohzaki K., Tsukada T., Shiomi M., Watanabe Y., Yazaki Y., Apolipoprotein E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits Journal of Clinical Investigation 1992 89 2 706 711
65. Nikoulin I. R., Curtiss L. K., An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo Journal of Clinical Investigation 1998 101 1 223 234 (Pubitemid 28058922)
66. Sharifov O. F., Nayyar G., Garber D. W., Handattu S. P., Mishra V. K., Goldberg D., Anantharamaiah G. M., Gupta H., Apolipoprotein E mimetics and cholesterol-lowering properties American Journal of Cardiovascular Drugs 2011 11 6 371 381
67. Nayyar G., Handattu S. P., Monroe C. E., Chaddha M., Datta G., Mishra V. K., Keenum T. D., Palgunachari M. N., Garber D. W., Anantharamaiah G. M., Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects Atherosclerosis 2010 213 2 449 457
68. Cioffi L., Sturtz F. G., Wittmer S., Barut B., Smith-Gbur J., Moore V., Zupancic T., Gilligan B., Auerbach R., Gomez F., Chauvin F., Antczak M., Platika D., Snodgrass H. R., A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E Gene Therapy 1999 6 6 1153 1159 (Pubitemid 29295222)
69. Tagalakis A. D., Diakonov I. A., Graham I. R., Heald K. A., Harris J. D., Mulcahy J. V., Dickson G., Owen J. S., Apolipoprotein E delivery by peritoneal implantation of encapsulated recombinant cells improves the hyperlipidaemic profile in apoE-deficient mice Biochimica et Biophysica Acta 2005 1686 3 190 199 (Pubitemid 40039146)
70. Shimano H., Yamada N., Katsuki M., Shimada M., Gotoda T., Harada K., Murase T., Fukazawa C., Takaku F., Yazaki Y., Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia Proceedings of the National Academy of Sciences of the United States of America 1992 89 5 1750 1754
71. Yamamoto K., Shimano H., Shimada M., Kawamura M., Gotoda T., Harada K., Ohsuga J. I., Yazaki Y., Yamada N., Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice Diabetes 1995 44 5 580 585
72. Bellosta S., Mahley R. W., Sanan D. A., Murata J., Newland D. L., Taylor J. M., Pitas R. E., Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice Journal of Clinical Investigation 1995 96 5 2170 2179
73. Linton M. F., Atkinson J. B., Fazio S., Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation Science 1995 267 5200 1034 1037
74. Shi W., Wang X., Wang N. J., McBride W. H., Lusis A. J., Effect of macrophage-derived apolipoprotein E on established atherosclerosis in apolipoprotein E-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 10 2261 2266
75. Kashyap V. S., Santamarina-Fojo S., Brown D. R., Parrott C. L., Applebaum-Bowden D., Meyn S., Talley G., Paigen B., Maeda N., Brewer H. B., Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors Journal of Clinical Investigation 1995 96 3 1612 1620
76. Tsukamoto K., Smith P., Glick J. M., Rader D. J., Liver-directed gene transfer and prolonged expression of three major human apoE isoforms in apoE-deficient mice Journal of Clinical Investigation 1997 100 1 107 114 (Pubitemid 27311248)
77. Tangirala R. K., Pratic D., FitzGerald G. A., Chun S., Tsukamoto K., Maugeais C., Usher D. C., Puré E., Rader D. J., Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E The Journal of Biological Chemistry 2001 276 1 261 266 (Pubitemid 32050315)
78. Harris J. D., Graham I. R., Schepelmann S., Stannard A. K., Roberts M. L., Hodges B. L., Hill V. J., Amalfitano A., Hassall D. G., Owen J. S., Dickson G., Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1 -, E31 -, polymerase1 - ] adenovirus vector expressing human apoE Human Molecular Genetics 2002 11 1 43 58 (Pubitemid 34100767)
79. Kim I. H., Jzkowicz A., Piedra P. A., Oka K., Chan L., Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector Proceedings of the National Academy of Sciences of the United States of America 2001 98 23 13282 13287 (Pubitemid 33051354)
80. Gao G. P., Alvira M. R., Wang L., Calcedo R., Johnston J., Wilson J. M., Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11854 11859 (Pubitemid 34994488)
81. Lebherz C., Gao G., Louboutin J. P., Millar J., Rader D., Wilson J. M., Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia Journal of Gene Medicine 2004 6 6 663 672 (Pubitemid 40228082)
82. Nakai H., Fuess S., Storm T. A., Muramatsu S. I., Nara Y., Kay M. A., Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice Journal of Virology 2005 79 1 214 224 (Pubitemid 39650967)
83. Chao H., Monahan P. E., Liu Y., Samulski R. J., Walsh C. E., Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors Molecular Therapy 2001 4 3 217 222 (Pubitemid 32851285)
84. Blankinship M. J., Gregorevic P., Allen J. M., Harper S. Q., Harper H., Halbert C. L., Miller A. D., Chamberlain J. S., Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6 Molecular Therapy 2004 10 4 671 678 (Pubitemid 39272856)
85. Louboutin J. P., Wang L., Wilson J. M., Gene transfer into skeletal muscle using novel AAV serotypes Journal of Gene Medicine 2005 7 4 442 451 (Pubitemid 40553125)
86. Thomas C. E., Storm T. A., Huang Z., Kay M. A., Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors Journal of Virology 2004 78 6 3110 3122 (Pubitemid 38314369)
87. McCarty D. M., Fu H., Monahan P. E., Toulson C. E., Naik P., Samulski R. J., Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo Gene Therapy 2003 10 26 2112 2118 (Pubitemid 37536760)
88. Nathwani A. C., Gray J. T., Ng C. Y. C., Zhou J., Spence Y., Waddington S. N., Tuddenham E. G. D., Kemball-Cook G., McIntosh J., Boon-Spijker M., Mertens K., Davidoff A. M., Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver Blood 2006 107 7 2653 2661
89. Osman E., Evans V., Graham I. R., Athanasopoulos T., McIntosh J., Nathwani A. C., Simons J. P., Dickson G., Owen J. S., Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice Atherosclerosis 2009 204 1 121 126
90. Wientgen H., Thorngate F. E., Omerhodzic S., Rolnitzky L., Fallon J. T., Williams D. L., Fisher E. A., Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 8 1460 1465 (Pubitemid 39050441)
91. Rinaldi M., Catapano A. L., Parrella P., Ciafr S. A., Signori E., Seripa D., Uboldi P., Antonini R., Ricci G., Farace M. G., Fazio V. M., Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA Gene Therapy 2000 7 21 1795 1801
92. Athanasopoulos T., Owen J. S., Hassall D., Dunckley M. G., Drew J., Goodman J., Tagalakis A. D., Riddell D. R., Dickson G., Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice Human Molecular Genetics 2000 9 17 2545 2551
93. Evans V., Foster H., Graham I. R., Foster K., Athanasopoulos T., Simons J. P., Dickson G., Owen J. S., Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adeno-associated virus (AAV2/7) Human Gene Therapy 2008 19 6 569 578 (Pubitemid 351913528)
94. Evans V. C., Graham I. R., Athanasopoulos T., Galley D. J., Jackson C. L., Simons J. P., Dickson G., Owen J. S., Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle Metabolism 2011 60 4 491 498
95. Smithies O., Gregg R. G., Boggs S. S., Koralewski M. A., Kucherlapati R. S., Insertion of DNA sequences into the human chromosomal -globin locus by homologous recombination Nature 1985 317 6034 230 234 (Pubitemid 16246494)
96. Thomas K. R., Folger K. R., Capecchi M. R., High frequency targeting of genes to specific sites in the mammalian genome Cell 1986 44 3 419 428 (Pubitemid 16043333)
97. Moerschell R. P., Tsunasawa S., Sherman F., Transformation of yeast with synthetic oligonucleotides Proceedings of the National Academy of Sciences of the United States of America 1988 85 2 524 528
98. Yoon K., Cole-Strauss A., Kmiec E. B., Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA DNA oligonucleotide Proceedings of the National Academy of Sciences of the United States of America 1996 93 5 2071 2076 (Pubitemid 26079882)
99. Cole-Strauss A., Yoon K., Xiang Y., Byrne B. C., Rice M. C., Gryn J., Holloman W. K., Kmiec E. B., Correction of the mutation responsible for sickle cell anemia by an RNA- DNA oligonucleotide Science 1996 273 5280 1386 1389 (Pubitemid 26296526)
100. Xiang Y., Cole-Strauss A., Yoon K., Gryn J., Kmiec E. B., Targeted gene conversion in a mammalian CD34+-enriched cell population using a chimeric RNA/DNA oligonucleotide Journal of Molecular Medicine 1997 75 11-12 829 835 (Pubitemid 27511558)
101. Thomas K. R., Capecchi M. R., Recombinant DNA technique and sickle cell anemia research Science 1997 275 5305 1404 1405 (Pubitemid 27111249)
102. Kren B. T., Cole-Strauss A., Kmiec E. B., Steer C. J., Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide Hepatology 1997 25 6 1462 1468 (Pubitemid 27250770)
103. Bandyopadhyay P., Ma Y., Linehan-Stieers C., Kren B. T., Steer C. J., Nucleotide exchange in genomic DNA of rat hepatocytes using RNA/DNA oligonucleotides: targeted delivery of liposomes and polyethyleneimine to the asialoglycoprotein receptor The Journal of Biological Chemistry 1999 274 15 10163 10172
104. Kren B. T., Banoyopaohyay P., Steer C. J., In vivo site-directed mutagenesis of the factor IX gene by chimetic RND/DNA oligonucleotides Nature Medicine 1998 4 3 285 290 (Pubitemid 28144085)
105. Kren B. T., Parashar B., Bandyopadhyay P., Chowdhury N. R., Chowdhury J. R., Steer C. J., Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 10349 10354 (Pubitemid 29422561)
106. Tagalakis A. D., Graham I. R., Riddell D. R., Dickson J. G., Owen J. S., Gene correction of the apolipoprotein (apo) E2 phenotype to wild-type apoE3 by in situ chimeraplasty The Journal of Biological Chemistry 2001 276 16 13226 13230
107. Tagalakis A. D., Dickson J. G., Owen J. S., Simons J. P., Correction of the neuropathogenic human apolipoprotein E4 (APOE4) gene to APOE3 in vitro using synthetic RNA/DNA oligonucleotides (chimeraplasts) Journal of Molecular Neuroscience 2005 25 1 95 103 (Pubitemid 41389369)
108. Albuquerque-Silva J., Vassart G., Lavinha J., Abramowicz M. J., Chimeraplasty validation Nature Biotechnology 2001 19 11, article 1011
109. Manzano A., Mohri Z., Sperber G., Ogris M., Graham I., Dickson G., Owen J. S., Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts) Journal of Gene Medicine 2003 5 9 795 802 (Pubitemid 40309717)
110. Gamper H. B., Cole-Strauss A., Metz R., Parekh H., Kumar R., Kmiec E. B., A plausible mechanism for gene correction by chimeric oligonucleotides Biochemistry 2000 39 19 5808 5816 (Pubitemid 30307969)
111. Gamper H. B., Parekh H., Rice M. C., Bruner M., Youkey H., Kmiec E. B., The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts Nucleic Acids Research 2000 28 21 4332 4339
112. Parekh-Olmedo H., Ferrara L., Brachman E., Kmiec E. B., Gene therapy progress and prospects: targeted gene repair Gene Therapy 2005 12 8 639 646 (Pubitemid 40561502)
113. Jensen N. M., Dalsgaard T., Jakobsen M., Nielsen R. R., Srensen C. B., Bolund L., Jensen T. G., An update on targeted gene repair in mammalian cells: methods and mechanisms Journal of Biomedical Science 2011 18 1, article 10
114. Radecke S., Radecke F., Peter I., Schwarz K., Physical incorporation of a single-stranded oligodeoxynucleotide during targeted repair of a human chromosomal locus Journal of Gene Medicine 2006 8 2 217 228 (Pubitemid 43250702)
115. Disterer P., Simons J. P., Owen J. S., Validation of oligonucleotide- mediated gene editing Gene Therapy 2009 16 6 824 826
116. Papaioannou I., Disterer P., Owen J. S., Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editing Journal of Gene Medicine 2009 11 3 267 274
117. Raffai R. L., McPherson R., Weisgraber K. H., Antibody phenotyping test for the human apolipoprotein E2 isoform Clinical Chemistry 2003 449 9 1524 1526 (Pubitemid 37011743)
118. Naldini L., Ex vivo gene transfer and correction for cell-based therapies Nature Reviews Genetics 2011 12 5 301 315
119. Sullivan G. J., Hay D. C., Park I. H., Fletcher J., Hannoun Z., Payne C. M., Dalgetty D., Black J. R., Ross J. A., Samuel K., Wang G., Daley G. Q., Lee J. H., Church G. M., Forbes S. J., Iredale J. P., Wilmut I., Generation of functional human hepatic endoderm from human induced pluripotent stem cells Hepatology 2010 51 1 329 335
120. Ghodsizadeh A., Taei A., Totonchi M., Seifinejad A., Gourabi H., Pournasr B., Aghdami N., Malekzadeh R., Almadani N., Salekdeh G. H., Baharvand H., Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells Stem Cell Reviews and Reports 2010 6 4 622 632
121. Choi S. M., Kim Y., Liu H., Chaudhari P., Ye Z., Jang Y. Y., Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells Cell Cycle 2011 10 15 2423 2427
122. Li H., Haurigot V., Doyon Y., Li T., Wong S. Y., Bhagwat A. S., Malani N., Anguela X. M., Sharma R., Ivanciu L., Murphy S. L., Finn J. D., Khazi F. R., Zhou S., Paschon D. E., Rebar E. J., Bushman F. D., Gregory P. D., Holmes M. C., High K. A., In vivo genome editing restores haemostasis in a mouse model of haemophilia Nature 2011 475 7355 217 221
123. Paiboonsukwong K., Ohbayashi F., Shiiba H., Aizawa E., Yamashita T., Mitani K., Correction of mutant Fanconi anemia gene by homologous recombination in human hematopoietic cells using adeno-associated virus vector Journal of Gene Medicine 2009 11 11 1012 1019
124. Mitsui K., Suzuki K., Aizawa E., Kawase E., Suemori H., Nakatsuji N., Mitani K., Gene targeting in human pluripotent stem cells with adeno-associated virus vectors Biochemical and Biophysical Research Communications 2009 388 4 711 717
125. Khan I. F., Hirata R. K., Wang P. R., Li Y., Kho J., Nelson A., Huo Y., Zavaljevski M., Ware C., Russell D. W., Engineering of human pluripotent stem cells by AAV-mediated gene targeting Molecular Therapy 2010 18 6 1192 1199
126. Vasileva A., Linden R. M., Jessberger R., Homologous recombination is required for AAV-mediated gene targeting Nucleic acids research. 2006 34 11 3345 3360
127. Liu G. H., Suzuki K., Qu J., Sancho-Martinez I., Yi F., Li M., Kumar S., Nivet E., Kim J., Soligalla R. D., Dubova I., Goebl A., Plongthongkum N., Fung H. L., Zhang K., Loring J. F., Laurent L. C., Izpisua Belmonte J. C., Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs Cell Stem Cell 2011 8 6 688 694
128. Aizawa E., Hirabayashi Y., Iwanaga Y., Suzuki K., Sakurai K., Shimoji M., Aiba K., Wada T., Tooi N., Kawase E., Suemori H., Nakatsuji N., Mitani K., Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors Molecular Therapy 2012 20 2 424 431
129. Pan H., Zhang W., Zhang W., Liu G. H., Find and replace: editing human genome in pluripotent stem cells Protein and Cell 2011 2 12 950 956
130. Thomas K. R., Deng C., Capecchi M. R., High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors Molecular and Cellular Biology 1992 12 7 2919 2923
131. Jasin M., Genetic manipulation of genomes with rare-cutting endonucleases
132. Porteus M. H., Baltimore D., Chimeric nucleases stimulate gene targeting in human cells Science 2003 300 5620 763 (Pubitemid 36532103)
133. Porteus M. H., Mammalian gene targeting with designed zinc finger nucleases Molecular Therapy 2006 13 2 438 446 (Pubitemid 43056910)
134. Porteus M., Using homologous recombination to manipulate the genome of human somatic cells Biotechnology and Genetic Engineering Reviews 2007 24 195 212 (Pubitemid 350032949)
135. Carroll D., Progress and prospects: zinc-finger nucleases as gene therapy agents Gene Therapy 2008 15 22 1463 1468
136. Rahman S. H., Maeder M. L., Joung J. K., Cathomen T., Zinc-finger nucleases for somatic gene therapy: the next frontier Human Gene Therapy 2011 22 8 925 933
137. Mussolino C., Cathomen T., On target? Tracing zinc-finger-nuclease specificity Nature Methods 2011 8 9 725 726
138. Pruett-Miller S. M., Reading D. W., Porter S. N., Porteus M. H., Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels PLoS Genetics 2009 5 2
139. Sander J. D., Dahlborg E. J., Goodwin M. J., Cade L., Zhang F., Cifuentes D., Curtin S. J., Blackburn J. S., Thibodeau-Beganny S., Qi Y., Pierick C. J., Hoffman E., Maeder M. L., Khayter C., Reyon D., Dobbs D., Langenau D. M., Stupar R. M., Giraldez A. J., Voytas D. F., Peterson R. T., Yeh J. R. J., Joung J. K., Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA) Nature Methods 2011 8 1 67 69
140. Isalan M., Zinc-finger nucleases: how to play two good hands Nature Methods 2012 9 1 32 34
141. Christian M., Cermak T., Doyle E. L., Schmidt C., Zhang F., Hummel A., Bogdanove A. J., Voytas D. F., Targeting DNA double-strand breaks with TAL effector nucleases Genetics 2010 186 2 756 761
142. Li T., Huang S., Zhao X., Wright D. A., Carpenter S., Spalding M. H., Weeks D. P., Yang B., Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes Nucleic Acids Research 2011 39 14 6315 6325
143. Mussolino C., Morbitzer R., Ltge F., Dannemann N., Lahaye T., Cathomen T., A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity Nucleic Acids Research 2011 39 21 9283 9293
144. Kues W. A., Niemann H., Advances in farm animal transgenesis Preventive Veterinary Medicine 2011 102 2 146 156
145. Silva G., Poirot L., Galetto R., Smith J., Montoya G., Duchateau P., Pques F., Meganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy Current Gene Therapy 2011 11 1 11 27
146. Hndel, E. M., Gellhaus K., Khan K., Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors Human Gene Therapy 2012 23 3 321 329
147. Asuri P., Bartel M. A., Vazin T., Jang J. H., Wong T. B., Schaffer D. V., Directed evolution of adeno-associated virus for enhanced gene delivery and gene targeting in human pluripotent stem cells Molecular Therapy 2012 20 2 329 338
148. Ellis B. L., Hirsch M. L., Porter S. N., Samulski R. J., Porteus M. H., Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs. Gene Therapy. In press
149. Chen F., Pruett-Miller S. M., Huang Y., Gjoka M., Duda K., Taunton J., Collingwood T. N., Frodin M., Davis G. D., High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases Nature Methods 2011 8 9 753 757
150. Soldner F., Laganire J., Cheng A. W., Hockemeyer D., Gao Q., Alagappan R., Khurana V., Golbe L. I., Myers R. H., Lindquist S., Zhang L., Guschin D., Fong L. K., Vu B. J., Meng X., Urnov F. D., Rebar E. J., Gregory P. D., Zhang H. S., Jaenisch R., Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations Cell 2011 146 2 318 331
151. Li T., Huang S., Zhao X., Wright D. A., Carpenter S., Spalding M. H., Weeks D. P., Yang B., Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes Nucleic Acids Research 2011 39 14 6315 6325
152. Baker M., Gene-editing nucleases Nature Methods 2012 9 1 23 26
153. Shore V. G., Shore B., Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components Biochemistry 1973 12 3 502 507